Clinical score and transcript abundance patterns identify kawasaki disease patients who may benefit from addition of Methylprednisolone

Pediatric Research

Volumn 66, Issue 5, 2009, Pages 577-584

  Ogata, Shohei ^a   Ogihara, Yoshihito ^a   Nomoto, Keiko ^a   Akiyama, Kazumasa ^a   Nakahata, Yayoi ^a   Sato, Kayoko ^c   Minoura, Katsunori ^c   Kenichi, Kokubo ^b   Kobayashi, Hirosuke ^b   Ishii, Masahiro ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c Ebina General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM BINDING PROTEIN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; GELATINASE B; IMMUNOGLOBULIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18 RECEPTOR; METHYLPREDNISOLONE; ONCOSTATIN M; PROTEIN S100A12; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ARTICLE; BRADYCARDIA; CHILD; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HYPERTENSION; HYPOTHERMIA; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE DRUG DOSE;

CORONARY VESSELS; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; METHYLPREDNISOLONE; MUCOCUTANEOUS LYMPH NODE SYNDROME; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOSTATIN M; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-18; RNA, MESSENGER; S100 PROTEINS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TREATMENT OUTCOME;

EID: 73249143055     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181baa3c2     Document Type: Article

References (28)

1. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H 1974 A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54:271-276
2. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP, Mason WH, Meissner HC, Rowley AH, Reddy V, Sundel RP, Melish ME, Rosen FS 1991 A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633-1639
3. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA 2004 Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708-1733 (Pubitemid 41754943)
4. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF 1995 The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96:1057-1061
5. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP 1998 Intravenous gamma-globulin, treatment and retreatment in Kawasaki disease US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 17:1144-1148
6. Muta H, Ishii M, Egami K, Furui J, Sugahara Y, Akagi T, Nakamura Y, Yanagawa H, Matsuishi T 2004 Early intravenous gamma-globulin, treatment for Kawasaki disease: the nationwide surveys in Japan. J Pediatr 144:496-499 (Pubitemid 38457354)
7. Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A 2006 Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113:2606-2612 (Pubitemid 43948009)
8. Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E, Eichenfield JR, Martin DD, Newburger JW, Bums JC 2008 Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr 153:117-121
9. Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T 2006 Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149:237-240 (Pubitemid 44128552)
10. Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, Kogaki S, Haia J 2007 Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166:131-137 (Pubitemid 46025504)
11. Okada K, Hara J, Maki I, Miki K, Matsuzaki K, Matsuoka T, Yamamoto T, Nishigaki T, Kurotobi S, Sano T 2009 Pulse methylprednisolone with gamma globulin as an initial treatment for acute Kawasaki disease. Eur J Pediatr 168:181185
12. Wright DA, Newburger JW, Baker A, Sundel RP 1996 Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 128:146-149 (Pubitemid 26028974)
13. Hashino K, Ishii M, Iemura M, Akagi T, Kato H 2001 Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int 43:211-217 (Pubitemid 32640933)
14. Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y 2008 Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease. Arch Dis Child 93:142-146 (Pubitemid 351204755)
15. Ogata S, Bando Y, Kimura S, Ando H, Nakahata Y, Ogihara Y, Kaneko T, Minoura K, Kaida M, Yokota Y, Furukawa S, Ishii M 2009 The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. J Cardiol 53:15-19
16. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, Ishii M, Harada K 2005 Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 47:232-234 (Pubitemid 40545436)
17. Nomura I, Abe J, Noma S, Saito H, Gao B, Wheeler G, Leung DY 2005 Adrenomedullin is highly expressed in blood monocytes associated with acute Kawasaki disease: a microarray gene expression study. Pediatr Res 57: 49-55 (Pubitemid 40039892)
18. Abe J, Jibiki T, Noma S, Nakajima T, Saito H, Terai M 2005 Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease. J Immunol 174:5837-5845 (Pubitemid 40593229)
19. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2 -ΔΔCT Method. Methods 25:402-408 (Pubitemid 34164012)
20. Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Nakano H, Nagasaka H, Sasaki N, Asano H, Kyo S, Yokote Y 2001 Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation 104:860-863 (Pubitemid 32778033)
21. Foell D, Ichida F, Vogl T, Yu X, Chen R, Miyawaki T, Sorg C, Roth J 2003 S100A12 (EN-RAGE) in monitoring Kawasaki disease. Lancet 361:12701272 (Pubitemid 36428584)
22. Nomura Y, Masuda K, Maeno N, Yoshinaga M, Kawano Y 2004 Serum levels of interleukin-18 are elevated in the subacute phase of Kawasaki syndrome. Int Arch Allergy Immunol 135:161-165 (Pubitemid 39370427)
23. Popper SJ, Shimizu C, Shike H, Kanegaye JT, Newburger JW, Sundel RP, Brown PO, Burns JC, Relman DA 2007 Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol 8:R261 (Pubitemid 351917513)
24. Abe J, Ebata R, Jibiki. T, Yasukawa K, Saito H, Terai M 2008 Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease. J Allergy Clin Immunol 122:1008-1013.e1008
25. Takeshita S, Tokutomi T, Kawase H, Nakatani K, Tsujimoto H, Kawamura Y, Sekine I 2001 Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease. Clin Exp Immunol 125:340-344 (Pubitemid 32758447)
26. Makala H, Ichiyama T, Uchi R, Takekawa T, Matsubara T, Furukawa S 2006 Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease. Naunyn Schmiedebergs Arch Pharmacol 373:325-332 (Pubitemid 44215578)
27. Suzuki A, Miyagawa-Tomita S, Komatsu K, Nakazawa M, Fukaya T, Baba K, Yutani C 2004 Immunohistochemical study of apparently intact coronary artery in a child after Kawasaki disease. Pediatr Int 46:590-596 (Pubitemid 39423208)
28. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, Nakamura Y, Yanagawa H, Wakui K, Fukushima Y, Kishi F, Hamamoto K, Terai M, Sato Y, Ouchi K, Saji T, Nariai A, Kaburagi Y, Yoshikawa T, Suzuki K, Tanaka T, Nagai T, Cho H, Fujino Fujino A, Sekine A, Nakamichi R, Tsunoda T, Kawasaki T, Nakamura Y, Hata A 2008 ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 40:35-42